Both in Pharmaceuticals
Polaryx Therapeutics vs Equillium
Over the past year PLYX returned −94.1% and EQ returned +7.3%; their daily moves had a correlation of 0.07.
PLYX −94.1% EQ +7.3%Growth of $1, one year, split-adjusted
| Metric | PLYX | EQ |
|---|---|---|
| Price | $2.07 | $1.62 |
| Market cap | $103.2M | $102.7M |
| Today | +1.47% | −3.57% |
| 1 month | +0.5% | −32.2% |
| 6 months | −68.7% | −7.4% |
| Year to date | — | +4.5% |
| 1 year | — | +8.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $57.2M |
| Dividend yield | — | — |
| Volatility (60d) | 76.3% | 80.6% |
| Short % of float | 1.5% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).